Literature DB >> 18349075

A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.

Romania Stilo1, Ettore Varricchio, Domenico Liguoro, Antonio Leonardi, Pasquale Vito.   

Abstract

The molecular complex containing CARMA proteins, BCL10 and TRAF6 has been identified recently as a key component in the signal transduction pathways that regulate activation of the nuclear factor kappaB (NF-kappaB) transcription factor. Here, we report that the inducible protein A20 negatively regulates these signaling cascades by means of its deubiquitylation activity. We show that A20 perturbs assembly of the complex containing CARMA3, BCL10 and IKKgamma/NEMO, thereby suppressing activation of NF-kappaB. Together, our results further define the molecular mechanisms that control activation of NF-kappaB and reveal a function for A20 in the regulation of CARMA and BCL10 activity in lymphoid and non-lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349075     DOI: 10.1242/jcs.021105

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  22 in total

1.  TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation.

Authors:  Tiziana Zotti; Antonio Uva; Angela Ferravante; Mariangela Vessichelli; Ivan Scudiero; Michele Ceccarelli; Pasquale Vito; Romania Stilo
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 3.  CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.

Authors:  Marie Lork; Kelly Verhelst; Rudi Beyaert
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

Review 4.  Expanding role of ubiquitination in NF-κB signaling.

Authors:  Siqi Liu; Zhijian J Chen
Journal:  Cell Res       Date:  2010-12-07       Impact factor: 25.617

Review 5.  Deubiquitinases in the regulation of NF-κB signaling.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Cell Res       Date:  2010-11-30       Impact factor: 25.617

6.  PSORS2 is due to mutations in CARD14.

Authors:  Catherine T Jordan; Li Cao; Elisha D O Roberson; Katherine C Pierson; Chi-Fan Yang; Cailin E Joyce; Caitriona Ryan; Shenghui Duan; Cynthia A Helms; Yin Liu; Yongqing Chen; Alison A McBride; Wuh-Liang Hwu; Jer-Yuarn Wu; Yuan-Tsong Chen; Alan Menter; Raphaela Goldbach-Mansky; Michelle A Lowes; Anne M Bowcock
Journal:  Am J Hum Genet       Date:  2012-04-19       Impact factor: 11.025

7.  A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.

Authors:  S Sakakibara; G Espigol-Frigole; P Gasperini; T S Uldrick; R Yarchoan; G Tosato
Journal:  Oncogene       Date:  2012-04-23       Impact factor: 9.867

8.  Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20.

Authors:  Shannon L Werner; Jeffrey D Kearns; Victoria Zadorozhnaya; Candace Lynch; Ellen O'Dea; Mark P Boldin; Averil Ma; David Baltimore; Alexander Hoffmann
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

9.  Bcl10 is an essential regulator for A20 gene expression.

Authors:  Wu Xu; Liquan Xue; Yi Sun; Aline Henry; Jennifer M Battle; Mathieu Micault; Stephan W Morris
Journal:  J Physiol Biochem       Date:  2013-05-16       Impact factor: 4.158

10.  MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage.

Authors:  Linda R Klei; Dong Hu; Robert Panek; Danielle N Alfano; Rachel E Bridwell; Kelly M Bailey; Katherine I Oravecz-Wilson; Vincent J Concel; Emily M Hess; Matthew Van Beek; Phillip C Delekta; Shufang Gu; Simon C Watkins; Adrian T Ting; Peter J Gough; Kevin P Foley; John Bertin; Linda M McAllister-Lucas; Peter C Lucas
Journal:  Cell Rep       Date:  2016-09-27       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.